Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B
bostonbased valo seriesmccoy wichita businessjournal
Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B — A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies.
Keep visiting teckno.blog for the latest news and updates.
Leave a reply
You must be logged in to post a comment.
